Skip the navigation buttons.
Home
ECTS Home Page
 

Scientific programme

Day-at-a-glance:
Saturday   Sunday   Monday   Tuesday   Wednesday

Overview Timetable [PDF]

 

Saturday 5 May, 2007
09:00 - 18:00 ECTS Training Course: Bone Quality: From Bench to Bedside
09:00 - 09:05  

Introduction and Welcome

09:05 - 09:40   BONE STRENGTH: INTRODUCTION - WHY DO WE NEED QUALITY TO COMPLEMENT BONE MINERAL DENSITY?
Graham Russell (Oxford, UK)
09:40 - 10:15   BASICS OF MECHANICS
Hans Schiessl (Pforzheim, Germany)
10:15 - 10:50   GENETICS AND BONE STRENGTH
Stuart Ralston (Edinburgh, UK)
 
    Coffee  
11:20 - 11:55   BONE TURNOVER
Richard Eastell (Sheffield, UK)
11:55 - 12:30   OVERSUPPRESSION: WHAT IS IT, AND DOES IT EXIST?
Socrates Papapoulos (Leiden, Netherlands)
   

Lunch

13:30 - 14:00  

POROSITY AND BONE STRENGTH
Nigel Loveridge (Cambridge, UK)

14:00 - 14:30   BONE MINERAL DENSITY AND MICRO-CT
Ralph Müller (Zurich, Switzerland)
14:30 - 15:00   BONE MATERIAL QUALITY
Peter Fratzl (Vienna, Austria)
    Coffee
15:30 - 16:00   BONE MINERAL DENSITY DISTRIBUTION
Paul Roschger (Vienna, Austria)
16:00 - 16:30   COLLAGEN
Simon Robins (Aberdeen, UK)
16:30   Summary and Discussion of Cases
11:00 - 12:30   Allied Health Professionals Session
11:00 - 12:30  

Satellite Symposium 1- Clinical Progress in Osteoporosis: Annual Bone Health Management

SUPPORTED BY NOVARTIS

  SS01 DEVELOPMENT OF LONG-ACTING BISPHOSPHONATES FOR ANNUAL THERAPY
Jürg Gasser (Basel, Switzerland)
  SS02 EFFECT OF ANNUAL BISPHOSPHONATE THERAPY ON HIP, SPINE, AND NON-SPINE FRACTURES
Steve Boonen (Leuven, Belgium)
  SS03 VERSATILITY OF THE ANNUAL BONE HEALTH MODEL: A CLOSER LOOK AT EFFICACY AMONG KEY PATIENT SUBGROUPS
Silvano Adami (Verona, Italy)
12:30 - 13:00   Break
13:00 - 14:30  

Satellite Symposium 2 - Teriparatide Reduces Fracture Risk by Improving Bone Strength in Patients with Severe Osteoporosis

SUPPORTED BY ELI LILLY

    TERIPARATIDE REDUCES FRACTURE INCIDENCE IN PATIENTS WITH ESTABLISHED OSTEOPOROSIS: THE EUROFORS STUDY
Richard Eastell (Sheffield, UK)
    RELEVANCE OF NONVERTEBRAL FRACTURES IN PATIENTS WITH OSTEOPOROSIS: THE PARADIGM IS SHIFTING
Pierre Delmas (Lyon, France)
    EFFECTS OF TERIPARATIDE ON BONE STRENGTH
Claus Glüer (Kiel, Germany)
14:30 - 15:00
  Break
15:00 - 16:30  

Satellite Symposium 3 - Foundation, Flexibility and Freedom: Optimising Osteoporosis Treatment

SUPPORTED BY NYCOMED

    PARATHYROID HORMONE: PHYSIOLOGICAL ROLE IN THE REGULATION OF SERUM CALCIUM CONCENTRATION
Robert Heaney (Omaha, USA)
    CALCIUM AND VITAMIN D SUPPLEMENTATION REVISITED
Steven Boonen (Liège, Belgium)
    BONE BUILDING: NEW HORIZONS FOR PTH IN THE TREATMENT OF OSTEOPOROSIS
Dennis Black (San Francisco, USA)

16:30 - 17:00

  Break
17:00 - 18:30  

Satellite Symposium 4 - Understanding the Facts - Improving Bone Strength and Preventing Fractures

SUPPORTED BY ROCHE/GSK

    DETERMINANTS OF BONE STRENGTH
Mary Bouxsein (Boston, USA)
    BONE REMODELLING, BISPHOSPHONATE DOSING AND FRACTURE RESISTANCE
Socrates Papapoulos (Leiden, Netherlands)
    BISPHOSPHONATE DOSING, BONE MINERAL DENSITY AND FRACTURE PREVENTION
Andreas Kurth (Frankfurt, Germany)
    ACCOMPLISHING FRACTURE REDUCTION WITH IBANDRONATE
Mike Stone (Cardiff, UK)
18:30 - 19:00
  Break
19:00 - 20:00   Opening Ceremony
19:00 - 19:15   Welcome to the Meeting and Introduction to Copenhagen
19:15 - 19:45   Keynote Address
  IS01 THE VITAMIN D PANDEMIC AND ITS HEALTH CONSEQUENCES
Michael Holick (Boston, USA)
19:45 - 20:00   Tivoli Pantomime Ballet
20:00 - 21:00   Welcome Reception

Sunday

  Scientific Programme    Meet the Professor    Allied Health Professionals Session  
  Other Events   Speaker Biographies  Call for Abstracts  Awards & Grants
     CPD/CME    Committees    Reviewers  
  Information for Presenters  

   
Go to top